One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor
Peter Jongho Na, MD, MPH1,4; Dilip V. Jeste, MD2; Robert H. Pietrzak, PhD, MPH3,4
doi : 10.1001/jamapsychiatry.2022.4162
February 2023, Vol 80, No. 2, Pages 100-191
The Need for Functional Assessments in School-Based Mental Health Intervention Research
Jack L. Andrews, PhD1; Susanne Schweizer, PhD1,2
Abortion and Mental Health—Context and Common Ground
Tyler J. VanderWeele, PhD1
Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA Network
Kirsten Bibbins-Domingo, PhD, MD, MAS1; Brian Shields, MBA2; John Z. Ayanian, MD, MPP3,4; Robert O. Bonow, MD, MS5,6; Neil M. Bressler, MD7,8; Dimitri Christakis, MD, MPH9,10; Mary L. Disis, MD11,12; S. Andrew Josephson, MD13,14; Melina R. Kibbe, MD15,16; Dost Öngür, MD, PhD17,18; Jay F. Piccirillo, MD19,20; Rita F. Redberg, MD, MPH21,22; Frederick P. Rivara, MD, MPH23,24; Kanade Shinkai, MD, PhD25,26; Thomas J. Easley27
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of LifeA Randomized Clinical Trial
Evan H. Goulding, MD, PhD1; Cynthia A. Dopke, PhD1; Rebecca Rossom, MD, MS2; Geneva Jonathan, MS1; David Mohr, PhD3; Mary J. Kwasny, ScD3
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated PsychosisA Cluster Randomized Clinical Trial
Tara A. Niendam, PhD1; Rachel Loewy, PhD2,3; Mark Savill, PhD2,3; Kevin L. Delucchi, PhD2,3; Tyler A. Lesh, PhD1; J. Daniel Ragland, PhD1; Khalima Bolden, PhD1; Haley V. Skymba, BS1; Sarah Gobrial, BS1; Monet S. Meyer, BS1; Katherine M. Pierce, BA1; Adi Rosenthal, BA1; Taylor L. Fedechko, BS1; Laura M. Tully, PhD1; Valerie L. Tryon, PhD; Howard Goldman, MD, PhD4; Rosemary D. Cress, PhD5; Richard L. Kravitz, MD6; Cameron S. Carter, MD1
Association Between State-Level Access to Reproductive Care and Suicide Rates Among Women of Reproductive Age in the United States
Jonathan Zandberg, PhD1; Rebecca Waller, PhD2; Elina Visoki, MSc3,4; Ran Barzilay, MD, PhD3,4,5
Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans
Nathan A. Kimbrel, PhD1,2,3,4; Allison E. Ashley-Koch, PhD5,6; Xue J. Qin, PhD1,5; Jennifer H. Lindquist, MS3; Melanie E. Garrett, MS5; Michelle F. Dennis, BA1,4; Lauren P. Hair, MA1,4; Jennifer E. Huffman, PhD7; Daniel A. Jacobson, PhD8,9,10; Ravi K. Madduri, PhD11,12; Jodie A. Trafton, PhD13; Hilary Coon, PhD14,15; Anna R. Docherty, PhD14,16; Niamh Mullins, PhD17,18; Douglas M. Ruderfer, PhD19,20,21; Philip D. Harvey, PhD22,23; Benjamin H. McMahon, PhD24; David W. Oslin, MD25,26; Jean C. Beckham, PhD1,2,4; Elizabeth R. Hauser, PhD1,5,27; Michael A. Hauser, PhD5,6; for the Million Veteran Program Suicide Exemplar Workgroup, the International Suicide Genetics Consortium, the Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center Workgroup, and the Veterans Affairs Million Veteran Program
Deep Learning for Cross-Diagnostic Prediction of Mental Disorder Diagnosis and Prognosis Using Danish Nationwide Register and Genetic Data
Rosa Lundbye Allesøe, MSc1,2; Wesley K. Thompson, PhD3; Jonas Bybjerg-Grauholm, PhD4,5; David M. Hougaard, MD, PhD4,5; Merete Nordentoft, MD, PhD1,4,6; Thomas Werge, PhD4,6,7; Simon Rasmussen, PhD2; Michael Eriksen Benros, MD, PhD1,8
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US
Krista F. Huybrechts, MS, PhD1; Loreen Straub, MD, MS1; Pär Karlsson, MSc2; Laura Pazzagli, PhD, MS2; Kari Furu, MPH, MScPharm, PhD3,4; Mika Gissler, PhD, MSocSc5,6; Sonia Hernandez-Diaz, MD, DrPH7; Mette Nørgaard, MD, PhD8; Helga Zoega, PhD, MA9,10; Brian T. Bateman, MD, MS11; Carolyn E. Cesta, PhD2; Jacqueline M. Cohen, PhD3,4; Maarit K. Leinonen, MD, PhD6; Johan Reutfors, MD, PhD2; Randi M. Selmer, PhD4; Elizabeth A. Suarez, MS, PhD1; Sinna Pilgaard Ulrichsen, MSc8; Helle Kieler, MD, PhD2,12
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study
Johan Lundberg, MD, PhD1,2; Thomas Cars, PhD3,4; Sven-Åke Lööv2; Jonas Söderling, PhD5; Johan Sundström, MD, PhD4,6; Jari Tiihonen, MD, PhD2,7,8,9; Amy Leval, PhD10,11; Anna Gannedahl10; Carl Björkholm, PhD10; Mikael Själin, MD10; Clara Hellner, MD, PhD1,2
Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults
Mette Bliddal, PhD1,2; Lotte Rasmussen, PhD2; Jacob Harbo Andersen, MSc2; Peter Bjødstrup Jensen, PhD2; Anton Pottegård, PhD2; Trine Munk-Olsen, PhD3; Helene Kildegaard, MD2; Rikke Wesselhoeft, PhD2,4
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia
Bochao D. Lin, PhD1,2,3,4; Justo Pinzón-Espinosa, MD, MSc4,5,6,7; Elodie Blouzard, MSc4; Marte Z. van der Horst, MD4,11; Cynthia Okhuijsen-Pfeifer, PhD4; Kristel R. van Eijk, PhD4; Sinan Guloksuz, MD, PhD1,8; Wouter J. Peyrot, MD, PhD9,10; Jurjen J. Luykx, MD, PhD1,2,4,11; for the Genetic Risk and Outcome of Psychosis (GROUP) and Clozapine International Consortium (CLOZIN) Investigators
Mass Violence and the Complex Spectrum of Mental Illness and Mental Functioning
James Knoll IV, MD1; Park Dietz, MD, MPH, PhD2,3,4
doi : 10.1001/jamapsychiatry.2022.4191
Psychiatry has struggled to clarify the types of mental turmoil that are associated with mass violence. While the problem is complex, it may present an opportunity to improve research, as well as inform public dialogue about what types of mental illness are actually associated with such mass tragedies.
The Heterogeneity of Posttraumatic Stress Disorder in DSM-5
Richard A. Bryant, PhD1; Isaac Galatzer-Levy, PhD2; Dusan Hadzi-Pavlovic, MPsych3
